Ligand Pharmaceuticals, Inc. (LGND)
280.18
-6.11
(-2.13%)
USD |
NASDAQ |
Aug 24, 16:00
280.04
-0.14
(-0.05%)
After-Hours: 20:00
Ligand Pharmaceuticals Price : 280.18 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 286.27 | 286.27 | 279.87 | 280.18 | 158235.0 |
| Aug 21, 2026 | 288.09 | 289.98 | 285.21 | 286.29 | 152536.0 |
| Aug 20, 2026 | 289.11 | 293.37 | 284.87 | 287.39 | 138945.0 |
| Aug 19, 2026 | 291.02 | 294.60 | 282.25 | 290.71 | 231199.0 |
| Aug 18, 2026 | 291.00 | 293.51 | 284.41 | 287.59 | 247481.0 |
| Aug 17, 2026 | 292.47 | 298.29 | 291.73 | 291.77 | 145604.0 |
| Aug 14, 2026 | 287.61 | 295.19 | 287.20 | 294.60 | 197210.0 |
| Aug 13, 2026 | 294.99 | 294.99 | 285.24 | 288.82 | 255440.0 |
| Aug 12, 2026 | 290.38 | 294.74 | 287.81 | 293.27 | 380028.0 |
| Aug 11, 2026 | 295.01 | 299.34 | 288.60 | 288.75 | 368556.0 |
| Aug 10, 2026 | 295.51 | 299.38 | 288.46 | 295.70 | 192188.0 |
| Aug 07, 2026 | 304.37 | 304.60 | 286.65 | 293.15 | 313612.0 |
| Aug 06, 2026 | 306.08 | 317.49 | 297.31 | 300.14 | 393774.0 |
| Aug 05, 2026 | 305.26 | 308.56 | 300.07 | 302.57 | 197095.0 |
| Aug 04, 2026 | 299.42 | 301.67 | 293.76 | 300.79 | 329156.0 |
| Aug 03, 2026 | 287.00 | 293.23 | 283.77 | 292.04 | 191741.0 |
| Jul 31, 2026 | 294.84 | 301.92 | 286.22 | 287.54 | 272287.0 |
| Jul 30, 2026 | 287.78 | 303.00 | 286.45 | 296.29 | 283319.0 |
| Jul 29, 2026 | 294.63 | 298.28 | 287.19 | 288.01 | 356725.0 |
| Jul 28, 2026 | 301.28 | 301.29 | 293.53 | 296.28 | 353456.0 |
| Jul 27, 2026 | 301.05 | 304.97 | 293.02 | 297.50 | 378443.0 |
| Jul 24, 2026 | 302.72 | 307.81 | 297.18 | 300.53 | 277028.0 |
| Jul 23, 2026 | 300.47 | 307.48 | 300.00 | 302.15 | 355489.0 |
| Jul 22, 2026 | 308.18 | 308.56 | 302.20 | 304.26 | 205463.0 |
| Jul 21, 2026 | 296.97 | 305.47 | 295.35 | 305.47 | 162769.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 273.04 |
| Eli Lilly & Co. | 1246.93 |
| Merck & Co., Inc. | 150.66 |
| Zevra Therapeutics, Inc. | 11.65 |
| Liquidia Corp. | 70.27 |
Price Related Metrics
| PE Ratio | 29.95 |
| PS Ratio | 20.13 |
| Price to Book Value | 5.769 |
| Price to Free Cash Flow | 48.80 |
| Earnings Yield | 3.34% |
| Market Cap | 5.581B |
| Operating PE Ratio | 58.42 |
| Normalized PE Ratio | 39.81 |